Drug intelligence / Profile preview

Glucoblock

Development stage
Preclinical
Lead developer
Green World
Administration
Oral
01

Overview

Glucoblock is a polyherbal dietary supplement formulated as a capsule, primarily utilized for the management of type 2 diabetes mellitus. It is characterized by its antidiabetic and antioxidant properties, which have been evaluated in preclinical models. Research indicates that Glucoblock effectively lowers fasting plasma glucose levels and improves insulin sensitivity, as evidenced by reductions in HOMA-IR values. Furthermore, the formulation exhibits significant antioxidant activity by increasing superoxide dismutase (SOD) levels and reducing total oxidant status (TOS) and oxidative stress index (OSI). The product typically contains a blend of botanical extracts, including Astragalus, Balsam Pear (Momordica charantia), Ginkgo Biloba, and Mulberry Leaf, which contribute to its phytochemical profile and therapeutic efficacy.

Brand names
GlucoblockGreen World Glucoblock Capsule
Other names
Glucoblock Capsule
02

Targets

Misfolded SOD1INSR (Insulin receptor)

Beyond the preview

Go deeper on Glucoblock.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucoblock.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call